Background Long-term patient-reported outcomes are needed to inform treatment decisions
for localized prostate cancer. Methods Patient-reported outcomes of 1643 randomly …

Current policies on early detection of prostate cancer create overdiagnosis and inequity with
minimal benefit Page 1 Current policies on early detection of prostate cancer create …

Fluorescence‐guided surgery (FGS) is poised to revolutionize surgical medicine through
near‐infrared (NIR) fluorophores for tissue‐and disease‐specific contrast. Clinical open and …

Background and objective Current management options for localized prostate cancer (PCa)
include radical prostatectomy (RP), radiotherapy (RT), and active surveillance (AS). Despite …

Purpose Optimal follow-up strategies following trimodal treatment for muscle invasive
bladder cancer play a crucial role in detecting and managing relapse and side-effects. This …

Background To further strengthen the voice of patients, Europa Uomo initiated the Europa
Uomo Patient Reported Outcome Study 2.0 (EUPROMS 2.0) in October 2021. Objective To …

Aims Focal therapy treats individual areas of tumour in non-metastatic prostate cancer in
patients unsuitable for active surveillance. The aim of this work was to evaluate the cost …

PURPOSE Our purpose was to describe the prevalence and predictors of symptom and
function clusters related to physical, emotional, and social components of general health …

Simple Summary Theranostic robot-assisted radical prostatectomy (T-RARP) means
adopting RARP as an integration of diagnosis and therapy, and this concept has rarely been …

Background and purpose Despite several prospective trials showing a clinical benefit of
combining external beam radiotherapy (EBRT) with brachytherapy boost (BTB) for the …